These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37422903)

  • 1. Comparison of different risk scores for Parkinson disease in a population-based 10-year study.
    Marini K; Seppi K; Kiechl S; Stockner H; Willeit P; Willeit J; Djamshidian A; Rungger G; Poewe W; Mahlknecht P
    Eur J Neurol; 2023 Oct; 30(10):3347-3352. PubMed ID: 37422903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of a Simple Parkinson's Disease Risk Score in a Longitudinal Population-Based Cohort.
    Marini K; Mahlknecht P; Tutzer F; Stockner H; Gasperi A; Djamshidian A; Willeit P; Kiechl S; Willeit J; Rungger G; Noyce AJ; Schrag A; Poewe W; Seppi K
    Mov Disord; 2020 Sep; 35(9):1658-1662. PubMed ID: 32491231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the Movement Disorders Society criteria for prodromal Parkinson's disease: A population-based 10-year study.
    Mahlknecht P; Gasperi A; Djamshidian A; Kiechl S; Stockner H; Willeit P; Willeit J; Rungger G; Poewe W; Seppi K
    Mov Disord; 2018 Mar; 33(3):405-413. PubMed ID: 29436728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts.
    Pilotto A; Heinzel S; Suenkel U; Lerche S; Brockmann K; Roeben B; Schaeffer E; Wurster I; Yilmaz R; Liepelt-Scarfone I; von Thaler AK; Metzger FG; Eschweiler GW; Postuma RB; Maetzler W; Berg D
    Mov Disord; 2017 Jul; 32(7):1025-1034. PubMed ID: 28509336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Emergence and Progression of Motor Dysfunction in Individuals at Risk of Parkinson's Disease.
    Simonet C; Mahlknecht P; Marini K; Seppi K; Gill A; Bestwick JP; Lees AJ; Giovannoni G; Schrag A; Noyce AJ
    Mov Disord; 2023 Sep; 38(9):1636-1644. PubMed ID: 37317903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the MDS research criteria for prodromal Parkinson's disease: Longitudinal assessment in a REM sleep behavior disorder (RBD) cohort.
    Fereshtehnejad SM; Montplaisir JY; Pelletier A; Gagnon JF; Berg D; Postuma RB
    Mov Disord; 2017 Jun; 32(6):865-873. PubMed ID: 28429825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PREDICT-PD: An online approach to prospectively identify risk indicators of Parkinson's disease.
    Noyce AJ; R'Bibo L; Peress L; Bestwick JP; Adams-Carr KL; Mencacci NE; Hawkes CH; Masters JM; Wood N; Hardy J; Giovannoni G; Lees AJ; Schrag A
    Mov Disord; 2017 Feb; 32(2):219-226. PubMed ID: 28090684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prodromal Parkinson's disease as defined per MDS research criteria in the general elderly community.
    Mahlknecht P; Gasperi A; Willeit P; Kiechl S; Stockner H; Willeit J; Rungger G; Sawires M; Nocker M; Rastner V; Mair KJ; Hotter A; Poewe W; Seppi K
    Mov Disord; 2016 Sep; 31(9):1405-8. PubMed ID: 27273736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of the Movement Disorder Society prodromal criteria in healthy G2019S-LRRK2 carriers.
    Mirelman A; Saunders-Pullman R; Alcalay RN; Shustak S; Thaler A; Gurevich T; Raymond D; Mejia-Santana H; Orbe Reilly M; Ozelius L; Clark L; Gana-Weisz M; Bar-Shira A; Orr-Utreger A; Bressman SB; Marder K; Giladi N;
    Mov Disord; 2018 Jul; 33(6):966-973. PubMed ID: 29603409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving estimation of Parkinson's disease risk-the enhanced PREDICT-PD algorithm.
    Bestwick JP; Auger SD; Simonet C; Rees RN; Rack D; Jitlal M; Giovannoni G; Lees AJ; Cuzick J; Schrag AE; Noyce AJ
    NPJ Parkinsons Dis; 2021 Apr; 7(1):33. PubMed ID: 33795693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Impairment in Individuals With Prodromal or Unrecognized Parkinson Disease.
    Miller-Patterson C; Hsu JY; Willis AW; Hamedani AG
    JAMA Neurol; 2023 Feb; 80(2):200-204. PubMed ID: 36534377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort.
    Beavan M; McNeill A; Proukakis C; Hughes DA; Mehta A; Schapira AH
    JAMA Neurol; 2015 Feb; 72(2):201-8. PubMed ID: 25506732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prodromal Parkinson disease in patients with idiopathic hyposmia.
    Marrero-González P; Iranzo A; Bedoya D; Serradell M; Niñerola-Baizán A; Perissinotti A; Gaig C; Vilaseca I; Alobid I; Santamaría J; Mullol J
    J Neurol; 2020 Dec; 267(12):3673-3682. PubMed ID: 32676768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Widening the Spectrum of Risk Factors, Comorbidities, and Prodromal Features of Parkinson Disease.
    Schrag A; Bohlken J; Dammertz L; Teipel S; Hermann W; Akmatov MK; Bätzing J; Holstiege J
    JAMA Neurol; 2023 Feb; 80(2):161-171. PubMed ID: 36342675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PREDICT-PD: identifying risk of Parkinson's disease in the community: methods and baseline results.
    Noyce AJ; Bestwick JP; Silveira-Moriyama L; Hawkes CH; Knowles CH; Hardy J; Giovannoni G; Nageshwaran S; Osborne C; Lees AJ; Schrag A
    J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):31-7. PubMed ID: 23828833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution and clustering of prodromal parkinsonian features in GBA1 carriers.
    Mullin S; Beavan M; Bestwick J; McNeill A; Proukakis C; Cox T; Hughes D; Mehta A; Zetterberg H; Schapira AHV
    Mov Disord; 2019 Sep; 34(9):1365-1373. PubMed ID: 31251436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison in detection of prodromal Parkinson's disease patients using original and updated MDS research criteria in two independent cohorts.
    Kulcsarova K; Ventosa JR; Feketeova E; Maretta M; Lesko N; Benca M; Han V; Gombosova L; Baloghova J; Slavkovska M; Brosmanova M; Vancova Z; Lepej J; Rabajdova M; Ambro L; Toth S; Kudela F; Kudela I; Strigacova L; Roskovicova V; Gdovinova Z; Skorvanek M
    Parkinsonism Relat Disord; 2021 Jun; 87():48-55. PubMed ID: 33964786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's disease.
    Mollenhauer B; Caspell-Garcia CJ; Coffey CS; Taylor P; Singleton A; Shaw LM; Trojanowski JQ; Frasier M; Simuni T; Iranzo A; Oertel W; Siderowf A; Weintraub D; Seibyl J; Toga AW; Tanner CM; Kieburtz K; Chahine LM; Marek K; Galasko D;
    Mov Disord; 2019 Sep; 34(9):1354-1364. PubMed ID: 31361367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four-Year Follow-up of [
    Kogan RV; Janzen A; Meles SK; Sittig E; Renken RJ; Gurvits V; Mayer G; Leenders KL; Oertel WH;
    Mov Disord; 2021 Jan; 36(1):230-235. PubMed ID: 32909650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.